Preclinical pharmacological evaluation of letrozole as a novel treatment for gliomas.
about
A review of the carcinogenic potential of bisphenol A.Anti-GD2-ch14.18/CHO coated nanoparticles mediate glioblastoma (GBM)-specific delivery of the aromatase inhibitor, Letrozole, reducing proliferation, migration and chemoresistance in patient-derived GBM tumor cells.Risk of malignant brain tumor as a second primary is significantly reduced after treatment of breast cancer.Investigation on the interaction of letrozole with herring sperm DNA through spectroscopic and modeling methods.
P2860
Preclinical pharmacological evaluation of letrozole as a novel treatment for gliomas.
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
2015年论文
@zh
2015年论文
@zh-cn
name
Preclinical pharmacological evaluation of letrozole as a novel treatment for gliomas.
@ast
Preclinical pharmacological evaluation of letrozole as a novel treatment for gliomas.
@en
type
label
Preclinical pharmacological evaluation of letrozole as a novel treatment for gliomas.
@ast
Preclinical pharmacological evaluation of letrozole as a novel treatment for gliomas.
@en
prefLabel
Preclinical pharmacological evaluation of letrozole as a novel treatment for gliomas.
@ast
Preclinical pharmacological evaluation of letrozole as a novel treatment for gliomas.
@en
P2093
P2860
P1476
Preclinical pharmacological evaluation of letrozole as a novel treatment for gliomas
@en
P2093
Gary A Gudelsky
Kathleen LaSance
Nimita Dave
Pankaj B Desai
Xiaoyang Qi
P2860
P304
P356
10.1158/1535-7163.MCT-14-0743
P50
P577
2015-02-18T00:00:00Z